Home/Filings/4/0001104659-24-042772
4//SEC Filing

Chan Phillip P. 4

Accession 0001104659-24-042772

CIK 0001175151other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 9:30 PM ET

Size

6.1 KB

Accession

0001104659-24-042772

Insider Transaction Report

Form 4
Period: 2024-03-29
Chan Phillip P.
DirectorInterim CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-29+129,998129,998 total
    Exercise: $0.95Exp: 2034-03-29Common Stock (129,998 underlying)
Footnotes (1)
  • [F1]The reporting person participated in a voluntary salary reduction for the period from April 1, 2024, to December 31, 2024, and these stock options were granted in connection with the salary reduction. These stock options were issued pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying these stock options will vest fully on January 31, 2025, except as set forth on the corresponding non-qualified stock option agreement and subject to the reporting person's continued service as of the applicable vesting date.

Issuer

Cytosorbents Corp

CIK 0001175151

Entity typeother

Related Parties

1
  • filerCIK 0001442786

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 9:30 PM ET
Size
6.1 KB